{"meta":{"query_hash":"d3ac228749f7","filters":{"venue":"Asia Pacific Clinical and Translational Nervous System Diseases"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d3ac228749f7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Asia+Pacific+Clinical+and+Translational+Nervous+System+Diseases"},"results":[{"id":"W2501244108","doi":"10.4103/2468-5577.187082","title":"Seven alternative opportunities to overcome the \"Valley of Death\" for CNS drug candidates developed by academic researchers","year":2016,"lang":"en","type":"article","venue":"Asia Pacific Clinical and Translational Nervous System Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Drug; Medicine; Intensive care medicine; Pharmacology","score_opus":0.24415136270456247,"score_gpt":0.3825053458334726,"score_spread":0.13835398312891015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501244108","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10996076,0.0855761,0.18323323,0.27646542,0.0029800076,0.00085991225,0.001158549,0.00079348235,0.3389725],"genre_scores_gemma":[0.761695,0.04594627,0.1253373,0.016159266,0.0027192424,0.0014815938,0.00067066593,0.00013224027,0.04585843],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953852,0.0027265958,0.00020330113,0.00025422362,0.0007874726,0.0006432996],"domain_scores_gemma":[0.99103606,0.005758246,0.0010354309,0.00036454643,0.00072236493,0.0010834213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076972893,0.00084567367,0.00088773854,0.0023131776,0.0020646635,0.0059818095,0.0013306056,0.0049836785,0.025352133],"category_scores_gemma":[0.010612818,0.000419118,0.001481858,0.001308782,0.002955308,0.0073149037,0.0052028536,0.004432822,0.0017021876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003160532,0.00020753403,0.0022276845,0.00066710566,0.000054039756,0.00042381644,0.00024660514,0.0029547648,0.00046679043,0.8573069,0.025796605,0.10933208],"study_design_scores_gemma":[0.0005073538,0.00054862374,0.0038725163,0.0013013557,0.000060018956,0.00062180194,0.0011074162,0.010444259,0.00084366737,0.8217182,0.15881504,0.00015968356],"about_ca_topic_score_codex":0.00062503654,"about_ca_topic_score_gemma":0.0015162482,"teacher_disagreement_score":0.025352133,"about_ca_system_score_codex":0.0018763408,"about_ca_system_score_gemma":0.0035820603,"threshold_uncertainty_score":0.08481127},"labels":[],"label_agreement":null}]}